2-pyrrolino-dox has been researched along with Kidney Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, B; Engel, JB; Gaiser, T; Halmos, G; Keller, G; Nagy, A; Schally, AV | 1 |
1 other study(ies) available for 2-pyrrolino-dox and Kidney Neoplasms
| Article | Year |
|---|---|
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; DNA, Complementary; Doxorubicin; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Kinetics; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Protein Binding; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |